Description

Maninil (glibenclamide) tablets 3.5 mg. №120 vial

Ingredients

Active ingredient: Glibenclamide 3.5 mg per tablet.

Dosage

Dosage: The usual starting dose is 2.5 to 5 mg daily, taken with breakfast or the first main meal. Dosage adjustments should be made based on blood glucose levels.

Indications

Indicated for: Maninil tablets are indicated for the treatment of type 2 diabetes mellitus when diet and exercise alone are not sufficient to control blood glucose levels.

Contraindications

Do not use Maninil tablets if:

• You have type 1 diabetes
• You have diabetic ketoacidosis
• You are allergic to sulfonylureas

Directions

Directions for use: Take Maninil tablets orally with a meal. Follow the dosage instructions provided by your healthcare provider.

Scientific Evidence

Studies have shown that glibenclamide, the active ingredient in Maninil tablets, effectively lowers blood glucose levels by stimulating insulin release from the pancreas. This mechanism of action helps in controlling hyperglycemia in patients with type 2 diabetes.

Research published in the American Journal of Medicine demonstrated the efficacy of glibenclamide in reducing HbA1c levels and improving glycemic control compared to placebo, highlighting its role as a valuable treatment option for diabetes management.

Additional Information

It is important to monitor blood glucose levels regularly while taking Maninil tablets to ensure optimal control of diabetes. Adhering to a healthy diet and regular exercise regimen is essential for maximizing the benefits of this medication.

Consult your healthcare provider for personalized advice on the use of Maninil tablets and to discuss any potential side effects or interactions with other medications you may be taking.